Effects of propranolol on fear of dental extraction: study protocol for a randomized controlled trial

Serge A Steenen, Arjen J van Wijk, Roos van Westrhenen, Jan de Lange, Ad de Jongh, Serge A Steenen, Arjen J van Wijk, Roos van Westrhenen, Jan de Lange, Ad de Jongh

Abstract

Background: Undergoing an extraction has been shown to pose a significantly increased risk for the development of chronic apprehension for dental surgical procedures, disproportionate forms of dental anxiety (that is, dental phobia), and symptoms of post-traumatic stress. Evidence suggests that intrusive emotional memories of these events both induce and maintain these forms of anxiety. Addressing these problems effectively requires an intervention that durably reduces both the intrusiveness of key fear-related memories and state anxiety during surgery. Moreover, evidence suggests that propranolol is capable of inhibiting "memory reconsolidation" (that is, it blocks the process of storing a recently retrieved fear memory). Hence, the purpose of this trial is to determine the anxiolytic and fear memory reconsolidation inhibiting effects of the ß-adrenoreceptor antagonist propranolol on patients with high levels of fear in anticipation of a dental extraction.

Methods/design: This trial is designed as a multicenter, randomized, placebo-controlled, two-group, parallel, double-blind trial of 34 participants. Consecutive patients who have been referred by their dentist to the departments of oral and maxillofacial surgery of a University hospital or a secondary referral hospital in the Netherlands for at least two tooth and/or molar removals and with self-reported high to extreme fear in anticipation of a dental extraction will be recruited. The intervention is the administration of two 40 mg propranolol capsules 1 hour prior to a dental extraction, followed by one 40 mg capsule directly postoperatively. Placebo capsules will be used as a comparator. The primary outcome will be dental trait anxiety score reduction from baseline to 4-weeks follow-up. The secondary outcomes will be self-reported anxiety during surgery, physiological parameters (heart rate and blood pressure) during recall of the crucial fear-related memory, self-reported vividness, and emotional charge of the crucial fear-related memory.

Discussion: This randomized trial is the first to test the efficacy of 120 mg of perioperative propranolol versus placebo in reducing short-term ("state") anxiety during dental extraction, fear memory reconsolidation, and lasting dental ("trait") anxiety in a clinical population. If the results show a reduction in anxiety, this would offer support for routinely prescribing propranolol in patients who are fearful of undergoing dental extractions.

Trial registration: ClinicalTrials.gov identifier: NCT02268357 , registered on 7 October 2014. The Netherlands National Trial Register identifier: NTR5364 , registered on 16 August 2015.

Figures

Fig. 1
Fig. 1
Flow-chart of study procedures

References

    1. Oosterink FMD, de Jongh A, Aartman IHA. What are people afraid of during dental treatment? Anxiety-provoking capacity of 67 stimuli characteristic of the dental setting. Eur J Oral Sci. 2008;116:44–51. doi: 10.1111/j.1600-0722.2007.00500.x.
    1. Sirin Y, Humphris G, Sencan S, Firat D. What is the most fearful intervention in ambulatory oral surgery? Analysis of an outpatient clinic. Int J Oral Maxillofac Surg. 2012;41:1284–90. doi: 10.1016/j.ijom.2012.06.013.
    1. American Dental Association . The 2005–06 Survey of Dental Services Rendered. Chicago IL: American Dental Association; 2007.
    1. Earl P. Patients’ anxieties with third molar surgery. Br J Oral Maxillofac Surg. 1994;32:293–7. doi: 10.1016/0266-4356(94)90049-3.
    1. Yusa H, Onizawa K, Hori M, Takeda S, Takeda H, Fukushima S, et al. Anxiety measurements in university students undergoing third molar extraction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:23–7. doi: 10.1016/j.tripleo.2003.12.017.
    1. de Jongh A, Olff M, van Hoolwerff H, Aartman IHA, Broekman B, Lindauer R, et al. Anxiety and post-traumatic stress symptoms following wisdom tooth removal. Behav Res Ther. 2008;46:1305–10. doi: 10.1016/j.brat.2008.09.004.
    1. de Jongh A, van Wijk AJ, Lindeboom JA. Psychological Impact of Third Molar Surgery: A 1-Month Prospective Study. J Oral Maxillofac Surg. 2011;69:59–65. doi: 10.1016/j.joms.2010.05.073.
    1. Lago-Méndez L, Diniz-Freitas M, Senra-Rivera C, Seoane-Pesqueira G, Gándara-Rey JM, García-García A. Postoperative recovery after removal of a lower third molar: role of trait and dental anxiety. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:855–60. doi: 10.1016/j.tripleo.2009.07.021.
    1. Aznar-Arasa L, Figueiredo R, Valmaseda-Castellón E, Gay-Escoda C. Patient anxiety and surgical difficulty in impacted lower third molar extractions: a prospective cohort study. Int J Oral Maxillofac Surg. 2014;43:1131–6. doi: 10.1016/j.ijom.2014.04.005.
    1. Lamont T, Matthew L, Cousins D, Green J. Avoiding midazolam overdose: summary of a safety report from the National Patient Safety Agency. BMJ. 2009;339:b4459. doi: 10.1136/bmj.b4459.
    1. van Minnen A, Arntz A, Keijsers GPJ. Prolonged exposure in patients with chronic PTSD: predictors of treatment outcome and dropout. Behav Res Ther. 2002;40:439–57. doi: 10.1016/S0005-7967(01)00024-9.
    1. Wide Boman U, Carlsson V, Westin M, Hakeberg M. Psychological treatment of dental anxiety among adults: a systematic review. Eur J Oral Sci. 2013;121(3 Pt 2):225–34. doi: 10.1111/eos.12032.
    1. Gordon D, Heimberg RG, Tellez M, Ismail AI. A critical review of approaches to the treatment of dental anxiety in adults. J Anxiety Disord. 2013;27:365–78. doi: 10.1016/j.janxdis.2013.04.002.
    1. Aartman I, Jongh A. Dental anxiety reduction and dental attendance after treatment in a dental fear clinic: a follow‐up study. Community Dent Oral Epidemiol. 2000;28:435–42. doi: 10.1034/j.1600-0528.2000.028006435.x.
    1. de Jongh A, Aartman IHA, Brand N. Trauma-related phenomena in anxious dental patients. Community Dent Oral Epidemiol. 2003;31:52–8. doi: 10.1034/j.1600-0528.2003.00025.x.
    1. De Jongh A, Fransen J, Oosterink-Wubbe F, Aartman I. Psychological trauma exposure and trauma symptoms among individuals with high and low levels of dental anxiety. Eur J Oral Sci. 2006;114:286–92. doi: 10.1111/j.1600-0722.2006.00384.x.
    1. Oosterink FMD, de Jongh A, Aartman IHA. Negative events and their potential risk of precipitating pathological forms of dental anxiety. J Anxiety Disord. 2009;23:451–7. doi: 10.1016/j.janxdis.2008.09.002.
    1. de Jongh A, Muris P, ter Horst G, Duyx MP. Acquisition and maintenance of dental anxiety: the role of conditioning experiences and cognitive factors. Behav Res Ther. 1995;33:205–10. doi: 10.1016/0005-7967(94)P4442-W.
    1. van Houtem CMHH, van Wijk AJ, de Jongh A. Presence, Content, and Characteristics of Memories of Individuals with Dental Phobia. Appl Cogn Psychol. 2015;29:515–23. doi: 10.1002/acp.3127.
    1. Berggren U. Psychosocial effects associated with dental fear in adult dental patients with avoidance behaviours. Psychol Health. 1993;8:185–96. doi: 10.1080/08870449308403178.
    1. Black JW, Crowther AF, Shanks RG, Smith LH, Dornhorst AC. A new adrenergic betareceptor antagonist. Lancet. 1964;1:1080–1. doi: 10.1016/S0140-6736(64)91275-9.
    1. Webb AJS, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375:906–15. doi: 10.1016/S0140-6736(10)60235-8.
    1. Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318:1730–7. doi: 10.1136/bmj.318.7200.1730.
    1. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice. Circulation. 2006;114:e257–354. doi: 10.1161/CIRCULATIONAHA.106.177292.
    1. Wheatley D. Comparative effects of propranolol and chlordiazepoxide in anxiety states. Br J Psychiatry. 1969;115:1411–2. doi: 10.1192/bjp.115.529.1411.
    1. Kathol RG, Noyes R, Slymen DJ, Crowe RR, Clancy J, Kerber RE. Propranolol in chronic anxiety disorders. A controlled study. Arch Gen Psychiatry. 1980;37:1361–5. doi: 10.1001/archpsyc.1980.01780250047005.
    1. Meibach RC, Dunner D, Wilson LG, Ishiki D, Dager SR. Comparative efficacy of propranolol, chlordiazepoxide, and placebo in the treatment of anxiety: a double-blind trial. J Clin Psychiatry. 1987;48:355–8.
    1. Grosz HJ. Narcotic withdrawal symptoms in heroin users treated with propranolol. Lancet. 1972;2:564–6. doi: 10.1016/S0140-6736(72)91959-9.
    1. Yorkston NJ, Zaki SA, Malik MK, Morrison RC, Havard CW. Propranolol in the control of schizophrenic symptoms. Br Med J. 1974;4:633–5. doi: 10.1136/bmj.4.5945.633.
    1. Ratey JJ, Bemporad J, Sorgi P, Bick P, Polakoff S, O’Driscoll G, et al. Open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults. J Autism Dev Disord. 1987;17:439–46. doi: 10.1007/BF01487073.
    1. Fleminger S, Greenwood RJ, Oliver DL. Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst Rev. 2006;4
    1. Brewer C. Beneficial effect of beta-adrenergic blockade on “exam. nerves”. Lancet. 1972;2:435. doi: 10.1016/S0140-6736(72)91840-5.
    1. Stone W, Gleser G, Gottschalk L. Anxiety and beta-adrenergic blockade. Arch Gen Psychiatry. 1973;29:620–2. doi: 10.1001/archpsyc.1973.04200050033005.
    1. Drew PJ, Barnes JN, Evans SJ. The effect of acute beta-adrenoceptor blockade on examination performance. Br J Clin Pharmacol. 1985;19:783–6. doi: 10.1111/j.1365-2125.1985.tb02714.x.
    1. Brantigan CO, Brantigan TA, Joseph N. Effect of beta blockade and beta stimulation on stage fright. Am J Med. 1982;72:88–94. doi: 10.1016/0002-9343(82)90592-7.
    1. Clark DB, Agras WS. The assessment and treatment of performance anxiety in musicians. Am J Psychiatry. 1991;148:598–605. doi: 10.1176/ajp.148.5.598.
    1. Elman MJ, Sugar J, Fiscella R, Deutsch TA, Noth J, Nyberg M, et al. The effect of propranolol versus placebo on resident surgical performance. Trans Am Ophthalmol Soc. 1998;96:283–94.
    1. Dyck JB, Chung F. A comparison of propranolol and diazepam for preoperative anxiolysis. Can J Anaesth. 1991;38:704–9. doi: 10.1007/BF03008446.
    1. Jakobsson J, Rane K, Ryberg G. Oral premedication one hour before minor gynaecological surgery--does it have any effect? A comparison between ketobemidone, lorazepam, propranolol and placebo. Acta Anaesthesiol Scand. 1995;39:359–63. doi: 10.1111/j.1399-6576.1995.tb04078.x.
    1. Mealy K, Ngeh N, Gillen P, Fitzpatrick G, Keane FB, Tanner A. Propranolol reduces the anxiety associated with day case surgery. Eur J Surg. 1996;162:11–4.
    1. Liu HH, Milgrom P, Fiset L. Effect of a beta-adrenergic blocking agent on dental anxiety. J Dent Res. 1991;70:1306–8. doi: 10.1177/00220345910700091401.
    1. Sevenster D, Beckers T, Kindt M. Prediction error governs pharmacologically induced amnesia for learned fear. Science. 2013;339:830–3. doi: 10.1126/science.1231357.
    1. Kindt M, Soeter M, Vervliet B. Beyond extinction: erasing human fear responses and preventing the return of fear. Nat Neurosci. 2009;12:256–8. doi: 10.1038/nn.2271.
    1. Debiec J, Ledoux JE. Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala. Neuroscience. 2004;129:267–72. doi: 10.1016/j.neuroscience.2004.08.018.
    1. Finnie PSB, Nader K. The role of metaplasticity mechanisms in regulating memory destabilization and reconsolidation. Neurosci Biobehav Rev. 2012;36:1667–707. doi: 10.1016/j.neubiorev.2012.03.008.
    1. Nader K, Schafe GE, Le Doux JE. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature. 2000;406:722–6. doi: 10.1038/35021052.
    1. Merlo E, Milton AL, Everitt BJ. Enhancing cognition by affecting memory reconsolidation. Curr Opin Behav Sci. 2015;4:41–7. doi: 10.1016/j.cobeha.2015.02.003.
    1. Merlo E, Milton AL, Goozee ZY, Theobald DE, Everitt BJ. Reconsolidation and Extinction Are Dissociable and Mutually Exclusive Processes: Behavioral and Molecular Evidence. J Neurosci. 2014;34:2422–31. doi: 10.1523/JNEUROSCI.4001-13.2014.
    1. Soeter M, Kindt M. Dissociating response systems: erasing fear from memory. Neurobiol Learn Mem. 2010;94:30–41. doi: 10.1016/j.nlm.2010.03.004.
    1. Johansen JP, Cain CK, Ostroff LE, LeDoux JE. Molecular mechanisms of fear learning and memory. Cell. 2011;147:509–24. doi: 10.1016/j.cell.2011.10.009.
    1. Lonergan MH, Olivera-Figueroa LA, Pitman RK, Brunet A. Propranolol’s effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysis. J Psychiatry Neurosci. 2013;38:222–31. doi: 10.1503/jpn.120111.
    1. Brunet A, Orr SP, Tremblay J, Robertson K, Nader K, Pitman RK. Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J Psychiatr Res. 2008;42:503–6. doi: 10.1016/j.jpsychires.2007.05.006.
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
    1. Oosterink FMD, de Jongh A, Hoogstraten J. Prevalence of dental fear and phobia relative to other fear and phobia subtypes. Eur J Oral Sci. 2009;117:135–43. doi: 10.1111/j.1600-0722.2008.00602.x.
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5. Washington, DC: American Psychiatric Association; 2013.
    1. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 2):22–33.
    1. Reynolds M, Brewin CR. Intrusive memories in depression and posttraumatic stress disorder. Behav Res Ther. 1999;37:201–15. doi: 10.1016/S0005-7967(98)00132-6.
    1. Pitman RK, Sanders KM, Zusman RM, Healy AR, Cheema F, Lasko NB, et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002;51:189–92. doi: 10.1016/S0006-3223(01)01279-3.
    1. McGaugh JL. Memory - a century of consolidation. Science. 2000;287:248–51. doi: 10.1126/science.287.5451.248.
    1. Aartman IH. Reliability and validity of the short version of the Dental Anxiety Inventory. Community Dent Oral Epidemiol. 1998;26:350–4. doi: 10.1111/j.1600-0528.1998.tb01972.x.
    1. van Wijk AJ, Makkes PC. Highly anxious dental patients report more pain during dental injections. Br Dent J. 2008;205 doi: 10.1038/sj.bdj.2008.583.
    1. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979;41:209–18. doi: 10.1097/00006842-197905000-00004.
    1. Joseph S. Psychometric evaluation of Horowitz’s Impact of Event Scale: a review. J Trauma Stress. 2000;13:101–13. doi: 10.1023/A:1007777032063.
    1. Kleber R, Brom D, Defares P. Coping with Trauma: Theory, Prevention and Treatment. Lisse: Swets and Zeitlinger; 1992.
    1. Hagenaars MA, van Minnen A, Hoogduin CAL, Verbraak M. A transdiagnostic comparison of trauma and panic memories in PTSD, panic disorder, and healthy controls. J Behav Ther Exp Psychiatry. 2009;40:412–22. doi: 10.1016/j.jbtep.2009.04.001.
    1. World Medical Association World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;20:2191.
    1. De Jongh A, Schutjes M, Aartman IHA. A test of Berggren’s model of dental fear and anxiety. Eur J Oral Sci. 2011;119:361–5. doi: 10.1111/j.1600-0722.2011.00843.x.
    1. Armfield JM, Stewart JF, Spencer AJ. The vicious cycle of dental fear: exploring the interplay between oral health, service utilization and dental fear. BMC Oral Health. 2007;7:1. doi: 10.1186/1472-6831-7-1.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever